Magenta Therapeutics, Inc. (NASDAQ:MGTA) Short Interest Down 56.0% in May

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Luigi Naldini ,Alan Tyndall ,Robert Negrin ,Davidt Scadden ,Johnf Dipersio ,Derrickj Rossi ,Susquehanna International Group ,Nasdaq ,Magenta Therapeutics Inc ,Acadian Asset Management ,Group Inc ,Atlas Venture Life Science Advisors ,Magenta Therapeutics ,Get Rating ,International Group ,Venture Life Science Advisors ,Asset Management ,Jason Gardner ,Magenta Therapeutics Daily ,Nasdaq Mgta ,Mgta ,Medical ,Stocks ,Options ,Put ,Call ,